For women with PCOS, the incidences of moderate/severe OHSS were 2.94% (95% CI 0.41–4.77) and 10.61% (95% CI 3.82–19.95) for the GnRH antagonist and GnRH agonist protocol, respectively. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.